QuantumScape's Q2 2025 highlights breakthroughs in battery tech and long-term EV market potential. Read more on why I ...

Valued at a market cap of $117.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company that ...

Explore why QuantumScape Corporation's recent drop may present a buying opportunity ahead of Q2 earnings. Click for my ...

QuantumScape shares are trading higher Tuesday afternoon. The stock is rebounding ahead of its Q2 earnings report, scheduled ...

Analysts estimate that QuantumScape will report an earnings per share (EPS) of $-0.19. QuantumScape bulls will hope to hear the company announce they've not only beaten that estimate, but also to ...

We recently published 10 Big Names Get Slammed. QuantumScape Corporation (NYSE:QS) is one of the biggest losers on Monday.

QuantumScape Corporation extended its winning streak to a third consecutive day on Thursday, adding 8.73 percent to close at $9.09 apiece as investors continued to scoop up shares ahead of the ...

The rally in shares of QuantumScape showed no signs of stopping on Friday, extending gains to a ninth consecutive day to hit ...

Atmos Energy is scheduled to report its third-quarter results next month, and analysts are projecting a modest double-digit ...

The expectation is for Q2 earnings to increase by +5% from the same period last year on +4% higher revenues. This will be a material deceleration from the growth trend of recent quarters and will ...